The yddH protein (UniProt accession: P76121) is a bacterial protein found in Escherichia coli strain K12 that has been identified as a potential target for investigating bacterial metabolism and stress responses. While comprehensive functional characterization is still ongoing, understanding this protein may provide insights into bacterial adaptation mechanisms and potential antimicrobial targets.
The yddH antibody enables detection and quantification of this protein across various experimental approaches, facilitating research into bacterial physiology, stress responses, and potential regulatory functions. Current evidence suggests yddH may be involved in metabolic pathways that respond to environmental changes, making it relevant for studies of bacterial adaptation .
Polyclonal yddH antibodies, such as the rabbit-derived variant, are generated using recombinant Escherichia coli (strain K12) yddH protein as the immunogen. These antibodies possess several important properties for research applications:
Isotype: IgG
Host species: Typically raised in rabbits
Form: Supplied as liquid formulation
Storage buffer: Commonly preserved in 50% glycerol with 0.01M PBS (pH 7.4) and 0.03% Proclin 300
Purification method: Antigen affinity purified to enhance specificity
Validated applications: ELISA and Western blotting (WB)
Unlike monoclonal antibodies, polyclonal preparations contain a heterogeneous mixture of antibodies recognizing multiple epitopes on the target protein, which can provide more robust detection across different experimental conditions.
Proper storage and handling of yddH antibodies is essential for maintaining their activity over time. Research protocols recommend:
Long-term storage: Upon receipt, store at -20°C or -80°C
Critical consideration: Avoid repeated freeze-thaw cycles as this can lead to protein denaturation and reduced activity
Working solutions: For short-term use, small aliquots can be maintained at 4°C for 1-2 weeks
Buffer considerations: The standard storage buffer (50% glycerol, 0.01M PBS, pH 7.4 with 0.03% Proclin 300) helps maintain stability during freeze-thaw cycles
Aliquoting strategy: Divide stock solutions into single-use volumes to minimize freeze-thaw cycles
For applications requiring diluted antibody preparations, adding carrier proteins such as BSA (0.1-1%) can enhance stability. Monitoring solution clarity before use is recommended, as cloudy solutions may indicate denaturation or aggregation that could affect binding specificity and sensitivity.
Western blotting with yddH antibody requires careful optimization for reliable results. A comprehensive protocol includes:
Sample preparation:
Bacterial lysate preparation using appropriate lysis buffers (e.g., RIPA buffer with protease inhibitors)
Protein quantification (BCA or Bradford assay)
Standardized loading (typically 20-30 μg total protein per lane)
Denaturation with reducing sample buffer at 95°C for 5 minutes
Electrophoresis and transfer:
SDS-PAGE separation (10-12% gels typically provide good resolution)
Transfer to PVDF or nitrocellulose membrane (0.45 μm pore size)
Verification of transfer efficiency with Ponceau S or similar reversible stain
Immunodetection:
Blocking: 5% non-fat dry milk or 3-5% BSA in TBST (1 hour at room temperature)
Primary antibody: Initial dilution range of 1:500-1:2000 in blocking buffer
Incubation period: Overnight at 4°C with gentle agitation
Washing: 3-5 washes with TBST, 5-10 minutes each
Secondary antibody: HRP-conjugated anti-rabbit IgG at 1:5000-1:10000
Incubation: 1 hour at room temperature
Final washing: 3-5 washes with TBST, 5-10 minutes each
Detection and analysis:
Enhanced chemiluminescence (ECL) substrate application
Imaging using digital systems or film exposure
Quantification through densitometry if needed
Signal optimization may require adjusting antibody concentration, incubation times, or detection reagents based on expression levels of yddH in the specific experimental system .
ELISA represents a sensitive quantitative method for detecting yddH protein. For optimal results, consider the following methodological approach:
Direct ELISA protocol:
Coating: Adsorb antigen (recombinant yddH or bacterial lysate) to plates in carbonate buffer (pH 9.6) overnight at 4°C
Blocking: 1-3% BSA in PBS for 1-2 hours at room temperature
Primary antibody: Apply yddH antibody at 1:1000-1:5000 dilution
Incubation: 2 hours at room temperature
Washing: 4-5 washes with PBS containing 0.05% Tween-20
Secondary antibody: HRP-conjugated anti-rabbit IgG at 1:5000-1:10000
Development: TMB or OPD substrate followed by stopping solution
Measurement: Read absorbance at 450 nm (TMB) or 490 nm (OPD)
Sandwich ELISA for complex samples:
Capture antibody: Coat plates with another antibody recognizing a different epitope of yddH
Sample addition: Apply bacterial lysates or fractions
Detection: Use yddH antibody followed by enzyme-conjugated secondary antibody
Signal development: As with direct ELISA
ELISA typically offers higher sensitivity than Western blotting, with limits of detection potentially reaching the pg/mL range with optimized conditions. Standard curves using purified recombinant yddH protein should be included for quantitative analysis .
Comprehensive validation of yddH antibody ensures reliable and reproducible results. A systematic validation approach includes:
Specificity testing:
Western blot analysis to confirm a single band at the expected molecular weight
Testing with E. coli yddH knockout strains as negative controls
Peptide competition assays to verify epitope specificity
Testing against closely related bacterial species to assess cross-reactivity
Sensitivity assessment:
Titration experiments to determine optimal working dilution
Standard curve generation using purified recombinant yddH protein
Signal-to-noise ratio determination across different sample preparations
Reproducibility verification:
Intra-assay precision (multiple replicates within the same experiment)
Inter-assay precision (replicates across different days/conditions)
Lot-to-lot consistency if using multiple antibody batches
Application-specific validation:
For each intended application (WB, ELISA, immunofluorescence), specific controls
Comparison with alternative detection methods where possible
Thorough validation provides confidence in experimental results and facilitates troubleshooting if unexpected outcomes occur .
Investigating protein-protein interactions involving yddH can provide insights into its biological function. Several methodological approaches utilizing the yddH antibody are available:
Co-immunoprecipitation (Co-IP):
Prepare bacterial lysates under non-denaturing conditions
Pre-clear lysates with protein A/G beads to reduce non-specific binding
Incubate with yddH antibody (typically 2-5 μg per mg of protein lysate)
Capture antibody-protein complexes with protein A/G beads
Wash extensively to remove non-specific interactions
Elute bound proteins and analyze by Western blotting or mass spectrometry
Proximity ligation assay (PLA):
Fix bacterial cells on slides or in suspension
Apply yddH antibody alongside antibodies against potential interaction partners
Use species-specific PLA probes with oligonucleotide tails
Perform rolling circle amplification and detection
Analyze signal indicating proteins in close proximity (<40 nm)
Pull-down assays with immunodetection:
Express tagged recombinant yddH as bait
Incubate with bacterial lysates to capture interacting proteins
Detect specific interactions using antibodies against proteins of interest
Confirm interactions bidirectionally (bait-prey reversal)
These methods can be combined with mass spectrometry for unbiased identification of the yddH interactome, providing insights into its functional networks .
Understanding the specific epitope recognized by yddH antibody is valuable for experimental design and interpretation. Several methodological approaches can be employed:
Peptide mapping:
Generate overlapping synthetic peptides spanning the yddH sequence
Test antibody binding to each peptide using ELISA
Identify minimal peptide sequence required for recognition
Map recognized sequences to structural models if available
Mutagenesis analysis:
Generate point mutations or truncations in recombinant yddH
Express and purify mutant proteins
Test antibody binding to identify critical residues
Correlate findings with structural information
Hydrogen-deuterium exchange mass spectrometry (HDX-MS):
X-ray crystallography or cryo-EM (for high-resolution analysis):
Determine structure of antibody-antigen complex
Identify precise atomic interactions at binding interface
Epitope characterization helps predict potential cross-reactivity, design blocking peptides, and develop improved antibodies for specific applications .
Immunofluorescence microscopy using yddH antibody can reveal valuable insights about subcellular localization and potential functional domains. A comprehensive protocol includes:
Sample preparation:
Culture E. coli under experimental conditions
Fix cells with 4% paraformaldehyde (10-15 minutes)
Optional permeabilization with 0.1-0.5% Triton X-100
Block with 3-5% BSA or normal serum
Antibody staining:
Primary antibody (yddH): Apply at 1:100-1:500 dilution
Incubate overnight at 4°C or 1-2 hours at room temperature
Wash thoroughly with PBS (3-5 times)
Secondary antibody: Apply fluorophore-conjugated anti-rabbit IgG (1:500-1:1000)
Incubate 1 hour at room temperature, protected from light
Wash thoroughly with PBS
Counterstain nucleoids with DAPI if desired
Mounting and imaging:
Mount with anti-fade mounting medium
Image using appropriate filter sets for the fluorophore
Collect Z-stacks for 3D reconstruction if needed
Controls and validation:
Secondary antibody-only control to assess background
Pre-immune serum control to assess specificity
Peptide competition to confirm epitope specificity
yddH knockout strain as negative control if available
Advanced imaging techniques such as super-resolution microscopy can provide enhanced resolution of yddH distribution patterns within bacterial cells .
Western blotting with yddH antibody may encounter several technical challenges. Here are common issues and methodological solutions:
No signal or weak signal:
Increase antibody concentration (try 1:200-1:500 dilution)
Extend primary antibody incubation time (overnight at 4°C)
Increase protein loading (30-50 μg total protein)
Use more sensitive detection methods (high-sensitivity ECL)
Verify transfer efficiency with reversible protein stain
Ensure protein of interest wasn't lost during transfer (optimize transfer conditions)
High background or non-specific bands:
Increase blocking time or agent concentration
Use more stringent washing (increase number and duration of washes)
Decrease primary and secondary antibody concentrations
Try different blocking agents (switch between milk and BSA)
Filter blocking solutions to remove particulates
Include 0.1-0.5% Tween-20 in antibody diluent
Multiple bands or unexpected patterns:
Test with pre-absorption using purified antigen
Optimize sample preparation to prevent protein degradation (add protease inhibitors)
Verify sample heating conditions (95°C for 5 minutes)
Consider possible post-translational modifications or isoforms
Use freshly prepared reagents, particularly reducing agents
A systematic approach to troubleshooting can identify the specific factors affecting antibody performance in Western blotting applications .
Batch-to-batch variability is an inherent challenge with polyclonal antibodies. To address this methodologically:
Standardization strategies:
Purchase larger quantities when possible for long-term studies
Perform side-by-side comparisons between old and new batches
Establish internal reference standards for each new batch
Document lot-specific working dilutions and performance characteristics
Validation protocol for new batches:
Test multiple dilutions to establish optimal concentration
Verify specificity against positive and negative controls
Compare signal-to-noise ratios across batches
Establish minimum performance criteria for acceptance
Normalization methods for quantitative applications:
Use internal loading controls consistently
Create standard curves with purified recombinant yddH
Apply batch-specific correction factors when comparing across batches
Consider relative quantification rather than absolute values
Long-term mitigation strategies:
Consider developing monoclonal antibodies for critical applications
Maintain reference samples for calibration across batches
Document specific applications where batch variation is most impactful
This comprehensive approach helps manage variability while maintaining experimental consistency across research projects .
When studying low-abundance yddH protein, several methodological approaches can improve detection sensitivity:
Sample enrichment techniques:
Immunoprecipitation to concentrate yddH before analysis
Subcellular fractionation to isolate compartments with higher yddH concentration
Protein precipitation methods to concentrate samples
Expression induction if studying recombinant systems
Detection system enhancements:
Switch to high-sensitivity ECL substrates for Western blotting
Implement amplified detection systems (tyramide signal amplification)
Use biotin-streptavidin systems for signal enhancement
Consider chemifluorescent detection with longer integration times
Antibody optimization:
Increase antibody concentration judiciously (balancing specificity)
Extend primary antibody incubation times (overnight at 4°C)
Optimize all blocking and washing steps
Consider direct labeling of primary antibody to reduce background
Instrumentation considerations:
Use more sensitive imaging systems (cooled CCD cameras)
Increase exposure times while monitoring background
Apply deconvolution algorithms for immunofluorescence
Consider digital stacking of multiple exposures
These approaches can significantly improve detection of low-abundance yddH protein without compromising specificity .
Integrating antibody-based methods with mass spectrometry creates powerful approaches for studying yddH protein:
Immunoprecipitation-mass spectrometry (IP-MS) workflow:
Prepare bacterial lysates under conditions preserving protein interactions
Immunoprecipitate using yddH antibody conjugated to support matrix
Wash extensively to remove non-specific binders
Elute bound proteins (mild conditions for interaction studies, denaturing for PTM analysis)
Process samples for proteomic analysis:
In-solution or in-gel digestion with trypsin
LC-MS/MS analysis using appropriate acquisition methods
Database searching against E. coli proteome
Post-translational modification analysis:
Enrich yddH protein via immunoprecipitation
Process for MS analysis with modification-specific considerations:
Phosphorylation: TiO₂ enrichment, neutral loss scanning
Glycosylation: Lectin enrichment, glycosidase treatments
Ubiquitination: K-ε-GG antibody enrichment
Analyze using high-resolution MS with appropriate fragmentation methods
Targeted quantification approaches:
Develop selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) assays
Use stable isotope-labeled peptide standards for absolute quantification
Apply to samples enriched by immunoprecipitation with yddH antibody
This integrated approach provides comprehensive characterization of yddH protein beyond what antibody-based methods alone can achieve .
Super-resolution microscopy with yddH antibody requires specific methodological considerations:
Sample preparation optimizations:
Use thinner bacterial smears or specialized mounting techniques
Optimize fixation protocols (balance between structure preservation and antibody access)
Consider cytoskeletal stabilization to prevent sample movement
Use smaller fluorophore conjugates or direct labeling approaches
Labeling strategies for different super-resolution techniques:
For STED: Select photostable dyes (ATTO647N, Abberior STAR dyes)
For STORM/PALM: Use photoconvertible fluorophores or photoswitchable dyes
For SIM: Focus on high signal-to-noise ratio with conventional fluorophores
Consider F(ab) fragments to minimize distance between epitope and fluorophore
Controls and validation requirements:
Include resolution standards in imaging sessions
Perform correlative microscopy with conventional techniques
Use multiple labeling approaches to validate structures
Implement drift correction and system calibration
Data analysis considerations:
Apply appropriate reconstruction algorithms
Use cluster analysis for quantifying protein distribution
Implement molecular counting techniques where applicable
Consider 3D reconstruction for spatial distribution analysis
Super-resolution techniques can reveal yddH distribution patterns at nanoscale resolution (20-100 nm), potentially identifying functional domains or interaction sites in bacterial cells .
Investigating yddH's potential role in bacterial stress responses requires systematic experimental design:
Expression analysis methodology:
Expose E. coli cultures to different stressors (oxidative, heat, pH, antibiotics)
Collect samples at multiple time points
Quantify yddH expression changes using:
Western blotting with appropriate loading controls
Quantitative ELISA assays
Flow cytometry of fixed/permeabilized bacteria
Compare with unstressed control conditions
Localization studies:
Track yddH localization under stress using immunofluorescence microscopy
Analyze potential redistribution or aggregation
Correlate localization patterns with stress intensity and cellular phenotypes
Consider time-lapse imaging for dynamic processes
Functional correlation methods:
Compare yddH expression profiles with stress survival rates
Analyze yddH knockout mutants for altered stress responses
Perform complementation studies with yddH variants
Investigate potential interaction partners under stress conditions
Data analysis framework:
Apply statistical methods appropriate for time-series data
Use clustering algorithms to identify stress-specific patterns
Integrate with transcriptomic and proteomic datasets when available
This comprehensive approach can elucidate whether yddH plays a functional role in bacterial adaptation to environmental stresses .
Adapting yddH antibody detection for high-throughput screening requires specialized methodological considerations:
Assay development approach:
Miniaturize detection methods to microplate formats (384 or 1536-well)
Optimize for minimal reagent consumption and handling steps
Develop robust positive and negative controls
Establish Z-factor >0.5 for screening validation
High-throughput compatible assay formats:
ELISA-based screens for compound effects on yddH expression
Homogeneous assay formats (AlphaLISA, HTRF) to minimize washing steps
Cell-based assays using automated immunofluorescence microscopy
Flow cytometry with yddH antibody for bacterial phenotyping
Implementation strategies:
Develop automated liquid handling protocols
Create standardized plate layouts with edge effect mitigation
Implement quality control metrics for batch processing
Develop data normalization approaches for plate-to-plate variation
Specialized screening applications:
Genetic library screens (transposon mutants, CRISPR libraries in suitable systems)
Chemical library screens for compounds affecting yddH expression or function
Environmental condition matrices for identifying yddH expression modulators
| Assay Format | Throughput (compounds/day) | Sensitivity | Equipment Requirements | Key Advantages |
|---|---|---|---|---|
| ELISA | 1,000-5,000 | High | Plate reader, liquid handler | Quantitative, established |
| AlphaLISA | 10,000-50,000 | Very high | Alpha plate reader | No-wash format, sensitive |
| High-content imaging | 5,000-20,000 | Medium | Automated microscope | Spatial information, multiplexing |
| Flow cytometry | 10,000-30,000 | Medium | Flow cytometer, sampler | Single-cell resolution |
This approach allows for systematic investigation of factors affecting yddH expression, localization, and function across large experimental spaces .
Post-translational modifications (PTMs) can significantly impact protein function. To study PTMs of yddH:
Modification-specific detection strategy:
Use yddH antibody for initial protein capture
Apply PTM-specific antibodies (phospho, acetyl, etc.) for detection
Alternatively, use sequential immunoprecipitation:
First IP with yddH antibody
Detect PTMs in enriched fraction
Validate with PTM-specific antibodies
Mass spectrometry integration:
Immunoprecipitate yddH using the antibody
Process for MS analysis with modification-specific considerations
Apply enrichment strategies for specific PTMs:
Phosphorylation: IMAC or metal oxide affinity chromatography
Acetylation: Anti-acetyl lysine antibodies
Ubiquitination: Anti-diGly antibodies
Analyze by LC-MS/MS with PTM-specific scan modes
Functional correlation studies:
Compare PTM profiles under different growth conditions
Correlate PTM changes with functional outputs
Use site-directed mutagenesis to validate PTM sites
Apply PTM-mimicking mutations to assess functional consequences
Proteomic analysis approach:
Map modified residues to protein structural models
Assess conservation of modification sites across species
Identify potential regulatory enzymes (kinases, acetylases, etc.)
Develop modified-specific detection methods for high-throughput analysis
These approaches can reveal regulatory mechanisms controlling yddH function through post-translational modifications .
Antibody conjugation expands the utility of yddH antibody for specialized applications:
Fluorophore conjugation methodology:
Direct labeling using commercial antibody labeling kits (Alexa Fluor, DyLight, etc.)
Typical protocol includes:
Antibody concentration adjustment (1-2 mg/mL optimal)
Reaction with NHS-ester or maleimide-activated fluorophores
Purification using size exclusion chromatography
Degree of labeling determination (3-8 fluorophores per antibody optimal)
Applications include direct immunofluorescence and flow cytometry
Enzyme conjugation approaches:
HRP conjugation for enhanced sensitivity in Western blotting and ELISA
Alkaline phosphatase for applications requiring stable signal development
Common methods include glutaraldehyde crosslinking or periodate oxidation
Validation requires activity assays and titration experiments
Biotin labeling technique:
Allows flexible detection through high-affinity streptavidin interaction
Use NHS-biotin or commercial biotinylation kits
Determine biotin:protein ratio using HABA assay
Applications include signal amplification and multidimensional staining
Nanoparticle conjugation strategy:
Gold nanoparticles for electron microscopy applications
Quantum dots for photostable fluorescence detection
Magnetic beads for immunoprecipitation and separation
Requires optimization of surface chemistry and blocking conditions
Each conjugation approach should be validated by comparing the modified antibody's performance to the native antibody in standard assays .